Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Using the therapy of early intervention with Qianyang Yuyin Granules to improve cognitive impairment caused by hypertension.
Using the therapy of early intervention with Qianyang Yuyin Granules to improve cognitive impairment caused by hypertension.
The investigators designed a multi-center randomized controlled clinical trial to study the security and effectiveness of this therapy.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Experimental Group | Therapy A : Basic treatment + Qianyang Yuyin Granules | ||
| Negative Control Group | Therapy B : Basic treatment | ||
| Positive Control Group | Therapy C : Basic treatment + Donepezil |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Changes of brain image | Measure and record the volume changes of diseased alba, the micro-structure changes of alba fasciculus by MRI to see if the therapy effect or not. | 24 weeks |
| Measure and assess the changes of VaDAS-cog ( Vascular Dementia Assessment Scale cognitive subscale ) among time points | Measure and record with VaDAS-cog | 12 weeks, 24 weeks, 48 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Measure and assess the changes of MMSE ( Mini-mental State Examination ) among time points | Measure and record with MMSE | 12 weeks, 24 weeks, 48 weeks |
| Measure and assess the changes of ADL ( Activity of Daily Living ) among time points |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patients with cognitive impairment caused by hypertension.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cheng Chang, PhD | Contact | +8613851821996 | chch1967@163.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jiangsu Province Hospital of Chinese Medcine | Recruiting | Nanjing | Jiangsu | 210000 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006973 | Hypertension |
| D060825 | Cognitive Dysfunction |
| ID | Term |
|---|---|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Blood sample; Urine sample.
Measure and record with ADL
| 12 weeks, 24 weeks, 48 weeks |
| Measure and assess the changes of CDR ( Clinical Dementia Rating ) among time points | Measure and record with CDR | 12 weeks, 24 weeks, 48 weeks |
| Incidence rate of outcome event | Record the outcome event and analyse the incidence rate | 24 weeks |
| Therapeutic effect | Measure and record patients' systolic and diastolic blood pressure and analyse related data | 24 weeks |
| Metabonomics | Measure and record the metabonomics ( Trx & TrxR ) index | 24 weeks |
| D001523 |
| Mental Disorders |